HRT Financial’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-321,376
Closed -$2.13M 5492
2026
Q1
$2.33M Buy
321,376
+21,658
+7% +$282K 0.01% 1513
2025
Q4
$5.09M Buy
+299,718
New +$3.05M 0.02% 778
2024
Q1
Sell
-14,681
Closed -$74K 3196
2023
Q4
$74K Buy
+14,681
New +$78.5K ﹤0.01% 1923
2023
Q2
Sell
-233,278
Closed -$1.01M 3395
2023
Q1
$1.01M Buy
+233,278
New +$1.07M 0.01% 939
2021
Q2
Sell
-11,753
Closed -$65K 3627
2021
Q1
$65K Buy
+11,753
New +$113K ﹤0.01% 2513

Other funds holding WVE

HRT Financial's WVE Position: Q2 2026 in Review

HRT Financial sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 321,376 shares — an estimated $2.13M sold.

HRT Financial first reported a position in WVE in Q1 2021 and held it in 5 quarters. The position peaked at $5.09M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • HRT Financial reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 321,376 Wave Life Sciences shares in Q2 2026, an estimated $2.13M.
  • HRT Financial first reported a position in Wave Life Sciences in Q1 2021 and held it in 5 quarters.
  • HRT Financial's Wave Life Sciences position peaked at $5.09M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.